Jose Medina-Smester, MD
Internal Medicine · Miami, FLNPI 1295053593
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (59.1%), travel and lodging and education — rather than concentrated in one kind of arrangement. 23 manufacturers reported payments, led by AstraZeneca at 35.6% of the total. Among internal medicine clinicians in FL with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 122 payments — averaging $46.79 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$2K
- Jazz Pharmaceuticals Inc.$1K
- Inspire Medical Systems, Inc.$631
- GSK$472
- Boehringer Ingelheim$341
- Harmony Biosciences LLC$162
- plus $864 from 17 others
What the payments were for
- Travel & lodging$1,92634%
- Food & beverage$3,37659%
- Education$4067%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 10 | $2,033 |
| Jazz Pharmaceuticals Inc. | 34 | $1,204 |
| Inspire Medical Systems, Inc. | 7 | $631 |
| GSK | 23 | $472 |
| Boehringer Ingelheim | 10 | $341 |
| Harmony Biosciences LLC | 7 | $162 |
| Regeneron Healthcare Solutions, Inc. | 5 | $148 |
| Mitsubishi Tanabe Pharma Development America, Inc. | 3 | $134 |
| Sanofi | 3 | $99 |
| Insmed, Inc. | 1 | $74 |
| Pacira Pharmaceuticals Incorporated | 1 | $70 |
| Grifols USA, LLC | 3 | $59 |
| Verona Pharma, Inc. | 2 | $56 |
| Curonix LLC | 2 | $36 |
| Kowa Pharmaceuticals America, Inc. | 2 | $29 |
| Johnson & Johnson | 2 | $24 |
| Philips North America LLC | 1 | $23 |
| Amgen | 1 | $21 |
| Baxter Healthcare | 1 | $21 |
| Lilly USA, LLC | 1 | $19 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 1 | $18 |
| Mylan Specialty L.p. | 1 | $17 |
| Gilead | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$5,708 in reported general payments places this provider in the 90th percentile of 8,530 internal medicine providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Zolpidem Tartrate | 42 | $275 |
Paid to pharmacies, not to this prescriber.
Other internal medicine in Miami
- Haytham ElgammalMiami$2.2M
- Richard AguilarMiami$239K
- Maria Delgado LelievreMiami$80K
- Marlow HernandezMiami$58K
- Steven CohnMiami$47K
- Joseph PiperatoMiami$45K
- Simon AbelsonMiami$44K
- Joel Brooks TamayoMiami$42K
- Keith RubinFort Lauderdale$2M
- Michael SensionFort Lauderdale$1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.